share_log

華康生物醫學:須予披露交易及給予實體貸款有關收購目標公司19%股權及提供貸款的還款安排

HUAKANG BIOMED: DISCLOSEABLE TRANSACTION AND ADVANCE TO ENTITY REPAYMENT ARRANGEMENT IN RELATION TO ACQUISITION OF 19% EQUITY INTEREST OF THE TARGET COMPANY AND PROVISION OF LOAN

HKEX ·  May 14 06:52
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more